Sanofi €8bn shows Europe is a market for jumbo deals
Sanofi, the French pharmaceutical company, this week priced the largest European corporate bond deal of 2018 — an €8bn six-tranche deal. The company used only European banks as global co-ordinators for the sale, as the euro market proved that it is a viable market for jumbo financings.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: